National Academies Press: OpenBook

Vaccine Safety Forum: Summaries of Two Workshops (1997)

Chapter:WORKSHOP AGENDA

« Previous: REFERENCES
Suggested Citation:"WORKSHOP AGENDA." Institute of Medicine. 1997. Vaccine Safety Forum: Summaries of Two Workshops. Washington, DC: The National Academies Press. doi: 10.17226/5881.
×

Workshop Agenda

INSTITUTE OF MEDICINE VACCINE SAFETY FORUM

Workshop on Research to Identify Risks for Adverse Events Following Vaccination: Mechanisms and Possible Means of Prevention

April 1, 1996

Washington, D.C.

8:25 a.m.

Introduction

Russell Alexander, Seattle-King County Health Department; Workshop Chair

8:30

Challenges for Vaccine Safety Research: Creating a Comprehensive System

James Hanson, NICHD

8:45

Immune Response to Vaccine Antigens

Ira Berkower, FDA

9:15

Anaphylaxis

Lynelle Phillips, CDC

9:35

Personal and Family History of Convulsions

Robert Chen, CDC

9:55

Using LLDBs to Identify Children at Risk

Robert Davis, University of Washington

10:15

Adverse Effects of Immunization of the Premature Infant

Genevieve Losonsky, University of Maryland

10:35

BREAK

Suggested Citation:"WORKSHOP AGENDA." Institute of Medicine. 1997. Vaccine Safety Forum: Summaries of Two Workshops. Washington, DC: The National Academies Press. doi: 10.17226/5881.
×

10:50

High-Titer Measles Vaccines: Gender, Mortality, and Immunologic Profile

Elizabeth Holt, Johns Hopkins University

Maria Elena Leon, Johns Hopkins University

Brian Ward, McGill University

11:40

Discussion

12:15 p.m.

LUNCH

1:15

Rubella and Arthritis

Hira Nakhasi, FDA

1:35

Genetic Risk Factors for Environmentally Associated Autoimmune Diseases

Frederick Miller, FDA

1:55

Jumping Genes, Genetics, and Molecular Memory

Howard Urnovitz, Calypte Biomedical Corporation

2:15

Research Needs, Perspective from Parents

Barbara Loe Fisher, National Vaccine Information Center

2:35

Methodologic Considerations in Studying People Receiving Multiple Antigens

Philip Pittman, USAMRIID

3:05

BREAK

3:20

Autoimmune Demyelinating Diseases

Henry McFarland, NINDS

3:40

Hepatitis B Vaccine and Autoimmune Demyelinating Diseases

Burton Waisbren, Waisbren Clinic

4:00

Learning Disorders and Vaccines

Marcel Kinsbourne

4:20

Discussion

5:00

ADJOURN

Suggested Citation:"WORKSHOP AGENDA." Institute of Medicine. 1997. Vaccine Safety Forum: Summaries of Two Workshops. Washington, DC: The National Academies Press. doi: 10.17226/5881.
×

PARTICIPANTS

E. Russell Alexander, Chief of Epidemiology, Seattle-King County Health Department, Seattle, Washington

Norman Baylor, Associate Director for Regulatory Policy, Food and Drug Administration, Rockville, Maryland

Judy Beeler, Medical Officer, Food and Drug Administration, Rockville, Maryland

Ira Berkower, Chief, Laboratory of Immunoregulation, Food and Drug Administration, Rockville, Maryland

Ann Bostrom, Assistant Professor, School of Public Policy, Georgia Institute of Technology, Atlanta, Georgia

M. Miles Braun, Medical Officer, Food and Drug Administration, Rockville, Maryland

Gregg Burgess, Vaccine Educator, Vaccine Information Center, Vienna, Virginia

K. Lynn Cates, Associate Professor of Pediatrics, Case Western Reserve University, School of Medicine, Rainbow Babies and Childrens Hospital, Cleveland, Ohio

Mary Ann Chaffee, Legislative Assistant, U.S. Senate, Washington, D.C.

Karen Chaitkin, Technical Information Specialist, Food and Drug Administration, Rockville, Maryland

Robert T. Chen, Chief, Vaccine Safety and Development Activity, Centers for Disease Control and Prevention, Atlanta, Georgia

Linda D. Cowan, Professor, Department of Biostatistics and Epidemiology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma

Dack Dalrymple, Senior Vice President, Bailey & Robinson

David M. Davis, Technical Information Specialist, Food and Drug Administration, Rockville, Maryland

Robert Davis, Assistant Professor, Department of Pediatrics and Department of Epidemiology, University of Washington, Seattle, Washington

Jose Luis DiFabio, Pan American Health Organization, Washington, D.C.

Jerome Donlon, Director, Office of Establishment Licensing and Product Surveillance, Food and Drug Administration/CBER, Rockville, Maryland

Susan S. Ellenberg, Director, Division of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, Maryland

Elaine C. Esber, Associate Director for Medical and International Affairs, Food and Drug Administration, Rockville, Maryland

Suggested Citation:"WORKSHOP AGENDA." Institute of Medicine. 1997. Vaccine Safety Forum: Summaries of Two Workshops. Washington, DC: The National Academies Press. doi: 10.17226/5881.
×

Geoffrey Evans, Chief Medical Officer, Division of Vaccine Injury Compensation, Rockville, Maryland

Gerald M. Fenichel, Professor of Neurology and Pediatrics, Chairman Department of Neurology, Vanderbilt University School of Medicine, Nashville, Tennessee

Amy Fine, Senior Policy Analyst, Association of Maternal and Child Health Programs, Washington, D.C.

Barbara Loe Fisher, President, National Vaccine Information Center, Vienna, Virginia

Jill A. Foster, Children's Hospital of Philadelphia, Pennsylvania

John Furesz, Former Director, Bureau of Biologics, Department of National Health, Health Canada, Ontario

Joan Fusco, Director of Business Development, North American Vaccine, Inc., Beltsville, Maryland

Maryann R. Gallagher, Consumer Safety Officer, Advertising and Promotional Labeling Staff, Food and Drug Administration, Rockville, Maryland

Elizabeth Goss, Associate, Fox, Bennett & Turner, Washington, D.C.

Marjorie A. Grant, Beaver Dam, Wisconsin

Jill G. Hackell, Senior Director, Clinical Research and Medical Affairs, Lederle-Praxis Biologicals Division, Pearl River, New York

James Hanson, Special Assistant to the Director, Center for Research for Mothers and Children, National Institute of Child Health and Human Development, Bethesda, Maryland

M. Carolyn Hardegree, Director, Office of Vaccines Research and Review, Food and Drug Administration, Rockville, Maryland

Elizabeth Holt, Assistant Professor, Department of International Health, School of Hygiene and Public Health, Johns Hopkins University, Baltimore, Maryland

Akira Homma, Pan American Health Organization, Washington, D.C.

Cynthia Howe, Project Director, Institute of Medicine, Washington, D.C.

Richard B. Johnston, Medical Director, March of Dimes Birth Defects Foundation, White Plains, New York

Marcel Kinsbourne, Research Professor, Center for Cognitive Studies, Tufts University, Winchester, Massachusetts

Michael S. Kramer, Professor, Department of Pediatrics, and of Epidemiology and Biostatistics, McGill University, Montreal, Quebec, Canada

Robert C. Kohberger, Wyeth-Lederle Vaccines, Pearl River, New York

Carol Krueger, VAERS Project Officer, Food and Drug Administration, Rockville, Maryland

Dale N. Lawrence, Chief, Medical Office for Vaccine Science, Division of AIDS, NIAID, Bethesda, Maryland

Suggested Citation:"WORKSHOP AGENDA." Institute of Medicine. 1997. Vaccine Safety Forum: Summaries of Two Workshops. Washington, DC: The National Academies Press. doi: 10.17226/5881.
×

Maria Elena Leon, Research Associate, Department of International Health, School of Hygiene and Public Health, Johns Hopkins University, Baltimore, Maryland

Genevieve Losonsky, Chief, Applied Immunology Laboratory, Center for Vaccine Development, University of Maryland, Baltimore, Maryland

Henry McFarland, Chief, Neuroimmunology Branch, National Institute of Neurological Diseases and Stroke, Bethesda, Maryland

Dorothy Majewski, Project Assistant, Institute of Medicine, Washington, D.C.

Marie Mann, Vaccine Injury Compensation Program, Health Resources Services Administration, Rockville, Maryland

Vincent Matanoski, Trial Attorney, Department of Justice, Washington, D.C.

Martha Mattheis, Chief Clinical and Regulatory Affairs Branch, NIAID, Rockville, Maryland

Paul M. Mendelman, Merck Research Laboratories, Mountain View, California

John H. Menkes, Professor Emeritus, UCLA, Beverly Hills, California

Frederick Miller, Medical Officer and Senior Investigator, Food and Drug Administration, Bethesda, Maryland

J. Anthony Morris, Chairman, Governing Board, The Bell of Atri, Inc., College Park, Maryland

Hira Nakhasi, Chief, Laboratory of Molecular Pharmacology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland

Manette Niu, Medical Officer, Food and Drug Administration, Rockville, Maryland

M. Louis Offen, Physician/Attorney, Johns Hopkins Medical Center, Bethesda, Maryland

Deborah Outlaw, Attorney

Margie Patlak, Science Writer, Washington, D.C.

Lynelle Phillips, Nurse Consultant, Vaccine Safety and Development Activity, Centers for Disee Control and Prevention, Atlanta, Georgia

Philip Pittman, Chief, Special Immunizations Branch, USA Medical Research Institute of Infectious Diseases, Ft. Detrick, Maryland

Robert Pless, Head, Vaccine-Associated Adverse Events Surveillance Section, Division of Immunization, Health Canada, Ontario

Robert H. Parrott, Director Emeritus, Professor, Children's Hospital National Medical Center, Washington, D.C.

Peter A. Patriarca, Associate Director, Division of Viral Products, Food and Drug Administration, Bethesda, Maryland

Regina Rabinovich, Chief, Clinical Studies Section and Assistant Director, Division of Microbiology and Infectious Diseases, NIAID, National Institutes of Health, Rockville, Maryland

Suggested Citation:"WORKSHOP AGENDA." Institute of Medicine. 1997. Vaccine Safety Forum: Summaries of Two Workshops. Washington, DC: The National Academies Press. doi: 10.17226/5881.
×

Suresh C. Rastogi, Deputy Director, Food and Drug Administration, Rockville, Maryland

Marion E. Ray, Attorney, Hunt, Lees, Farrel and Kessler, Charleston, West Virginia

Mary Jane Reynolds, Project Coordinator, Center for Immunization Research, Johns Hopkins University, Baltimore, Maryland

Marcel E. Salive, Chief, Epidemiology Branch, Food and Drug Administration, Rockville, Maryland

Barbara Savarese, Medical Officer, Division of AIDS, NIH, Bethesda, Maryland

Helen Miller Scott, Microbiologist, USAMRIID, Fort Detrick, Maryland

Robert G. Sharrar, Director, Report Evaluation and Safety Surveillance, Worldwide Product Safety and Epidemiology, Merck Research Laboratories, West Point, Pennsylvania

Judith Shindman, Medical Director, Medical Affairs, Connaught Laboratories Ltd., Ontario

Howard R. Six, Vice President, Research and Development, Connaught Laboratories Inc., Swiftwater, Pennsylvania

William M. Stevens, Public Health Advisor, Food and Drug Administration, Rockville, Maryland

Paul D. Stolley, Professor and Chairman, Epidemiology and Preventive Medicine, University of Maryland School of Medicine, Baltimore, Maryland

Kathleen Stratton, Study Director, and Deputy Director, Division of Health Promotion and Disease Prevention, Institute of Medicine, Washington, D.C.

David L. Terzian, Attorney, Torts Branch, Civil Division, U.S. Department of Justice, Washington, D.C., and Edmund C. Tramont, Professor and Director, University of Maryland Biotechnology Center, Baltimore, Maryland

Dennis W. Trent, Director, Division of Viral Products, Food and Drug Administration, Rockville, Maryland

Frederick Varricchio, Medical Officer, Food and Drug Administration, Rockville, Maryland

Howard Urnovitz, Chief Scientific Officer, Calypte Biomedical Corporation, Berkeley, California

Burton Waisbren, Internist, Waisbren Clinic, Milwaukee, Wisconsin

Brian Ward, Assistant Professor, Faculty of Medicine, McGill University, Montreal, Quebec

Robert E. Weibel, Senior Medical Officer, Vaccine Injury Compensation Program, Rockville, Maryland

Dena Wichansky, Program Assistant, Immunization Education and Action Center, Healthy Mothers Healthy Babies Coalition, Washington, D.C.

Suggested Citation:"WORKSHOP AGENDA." Institute of Medicine. 1997. Vaccine Safety Forum: Summaries of Two Workshops. Washington, DC: The National Academies Press. doi: 10.17226/5881.
×

Kathi Williams, Director, National Vaccine Information Program, Vienna, Virginia

Robert P. Wise, Medical Epidemiologist, FDA, Rockville, Maryland

Suggested Citation:"WORKSHOP AGENDA." Institute of Medicine. 1997. Vaccine Safety Forum: Summaries of Two Workshops. Washington, DC: The National Academies Press. doi: 10.17226/5881.
×
Page57
Suggested Citation:"WORKSHOP AGENDA." Institute of Medicine. 1997. Vaccine Safety Forum: Summaries of Two Workshops. Washington, DC: The National Academies Press. doi: 10.17226/5881.
×
Page58
Suggested Citation:"WORKSHOP AGENDA." Institute of Medicine. 1997. Vaccine Safety Forum: Summaries of Two Workshops. Washington, DC: The National Academies Press. doi: 10.17226/5881.
×
Page59
Suggested Citation:"WORKSHOP AGENDA." Institute of Medicine. 1997. Vaccine Safety Forum: Summaries of Two Workshops. Washington, DC: The National Academies Press. doi: 10.17226/5881.
×
Page60
Suggested Citation:"WORKSHOP AGENDA." Institute of Medicine. 1997. Vaccine Safety Forum: Summaries of Two Workshops. Washington, DC: The National Academies Press. doi: 10.17226/5881.
×
Page61
Suggested Citation:"WORKSHOP AGENDA." Institute of Medicine. 1997. Vaccine Safety Forum: Summaries of Two Workshops. Washington, DC: The National Academies Press. doi: 10.17226/5881.
×
Page62
Suggested Citation:"WORKSHOP AGENDA." Institute of Medicine. 1997. Vaccine Safety Forum: Summaries of Two Workshops. Washington, DC: The National Academies Press. doi: 10.17226/5881.
×
Page63
Vaccine Safety Forum: Summaries of Two Workshops Get This Book
×
Buy Paperback | $47.00 Buy Ebook | $37.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

On November 6, 1995, the Institute of Medicine's Vaccine Safety Forum convened a workshop on detecting and responding to adverse events following vaccination. Workshop speakers and participants discussed the difficulties in detecting adverse events, current adverse events detection and response methods and procedures, suggestions for improving the means of detecting and responding to adverse events following vaccination, and future areas of research. This document represents a summary of that workshop.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!